Close this search box.

Investor Draper: nothing wrong with Theranos

There is nothing wrong with Theranos. That is the basic message Tim Draper gives in a Bloomberg video interview. Draper, founding partner of Draper Fisher Jurvetson (DFJ) and longtime investor in Theranos, comments on all recent negative news concerning the company, during an interview with Bloomberg's Emily Chang and Brad Stone at the 2016 Global Entrepreneurship Summit in Stanford, California.

According to Draper, Theranos is being attacked by the powers that be, just as has happend with taxi-app provider Uber. Draper is pointing at medical insurance companies, people in governments and other stakeholders that will be very much affected by the cheap blood test Theranos has been providing.

Theranos has been subjected to a controversy ever since the Wall Street Journal questioned the reliability of the blood testing Theranos offers. These tests are widely used as a cheaper an quicker alternative for traditional blood tests. Not longer after the articles in the WSJ a research by the US Centers for Medicare and Medicaid Services concluded Theranos’ Northern California lab was putting patients in ‘immediate jeopardy’. The lab hasn’t done any testing since.

Draper finds it remarkable that Theranos has been subjected to government scrutiny, since all competitors have never had any likewise inspections. Draper says these competitors are trying to push Theranos out of the market, even though consumers love the quick and simple blood test that requires only a very small amounth of blood. 

The DFJ founding partner goes on to say that Theranos’ CEO and founder Elisabeth Holmes is one of the great entrepeneurs of this time period. She is most definitely the right person for the job, he concludes.


ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
How to introduce innovation and AI in healthcare organizations if there is no business model for prevention and quality – Our interview with Professor Ran Balicer, the Chief Innovation Officer at Clalit Health Services and founding Director of Clalit Research Institute.
I see no legitimate rationale for delaying the digital transformation in healthcare
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
EIT 2024
EIT Awards 2024. Two European startups are revolutionizing the treatment of cardiovascular diseases
Bertrand Piccard, Swiss explorer and founder of the Solar Impulse Foundation
EIT Summit 2024. What are the trigger points that drive or inhibit innovation?
MMC pioneers wireless monitoring for premature infants with the innovative Bambi Belt, revolutionizing care with improved comfort and mobility.
Wireless Monitoring of Vital Signs in Premature Infants at Máxima MC
Innovation Adoption: How to Traverse The Valleys of Death
Data protection-critical incidents resulting from human error are often rooted in stress, routine, negative attitudes toward IT, and deficits in employees' identification with the healthcare facility.
How cyberpsychology helps prevent human errors leading to data leaks
What technologies will enter our homes in a few months? ICT&health checked it out at the CES 2024.
CES 2024: Meet the exciting innovations for health and well-being
An article on a new study on e-health assessment tools
eHealth success lies at the intersection of technology, people, and organization
Follow us